Switching from natalizumab to fingolimodLudwig Kappos, Athanasios P. Kyritsis, Helmut Butzkueven et al.|Neurology|2015Cited by 116
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsPetros Skapinakis, Venetsanos Mavreas, Eleni Bakola et al.|BMC Neurology|2010Cited by 106